We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8113:TSEUnicharm Corporation Analysis

Data as of 2026-06-11 - not real-time

HK$0.46

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at HK$0.455, which sits comfortably above its DCF‑derived fair value of roughly HK$0.32, suggesting a pricing premium. Technical patterns show the 20‑day SMA (~0.47) comfortably above the 50‑day (~0.42) and 200‑day (~0.40) averages, reinforcing a bullish trend, while the RSI hovers around the mid‑50s, indicating neither overbought nor oversold conditions. However, the MACD histogram has turned negative and the signal line is bearish, and trading volume has been on a decline, raising caution about short‑term momentum. Volatility is unusually high at over 80% on a 30‑day basis, though the beta is modest (~0.38), implying the stock’s moves are more idiosyncratic than market‑driven.
Fundamentally, the company posts thin margins (gross ~3.4%, operating ~0.7%) and modest revenue growth of about 5‑6%, while shouldering a heavy debt load that pushes the debt‑to‑equity ratio above 160%. Return metrics are weak (ROE ~3.8%, ROA ~1.5%) and the PE of 22.8 is well below the sector average of 36.5, yet the DCF gap and lack of dividend support an overvalued view. The balance sheet, combined with decreasing liquidity and a small market cap, amplifies risk considerations across the medium to long horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price is near recent support level
  • Bearish MACD histogram despite overall bullish trend
  • Decreasing trading volume adds uncertainty

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Overvaluation relative to DCF fair value
  • Weak profitability and high leverage
  • Industry demand remains stable but margins are thin

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Sustained overvaluation without clear catalyst
  • Elevated debt burden limiting financial flexibility
  • Low return metrics and high volatility signal heightened risk

Key Metrics & Analysis

Financial Health

Revenue Growth5.60%
Profit Margin0.38%
P/E Ratio22.8
ROE3.84%
ROA1.48%
Debt/Equity164.64
P/B Ratio0.7
Op. Cash FlowHK$21.7M
Free Cash FlowHK$7.5M
Industry P/E36.5

Technical Analysis

TrendBullish
RSI53.7
SupportHK$0.44
ResistanceHK$0.52
MA 20HK$0.47
MA 50HK$0.42
MA 200HK$0.40
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71

Valuation

Fair ValueHK$0.32
GradeOvervalued
TypeValue

Risk Assessment

Beta0.38
Volatility86.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.